β2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis

Wen Chin Huang, Daqing Wu, Zhihui Xie, Haiyen E. Zhau, Takeo Nomura, Majd Zayzafoon, Jan Pohl, Chia Ling Hsieh, M. Neale Weitzmann, Mary C. Farach-Carson, Leland W.K. Chung

Research output: Contribution to journalArticlepeer-review

98 Scopus citations

Abstract

The protein factor β2-microglobulin (β2M), purified from the conditioned medium of human prostate cancer cell lines, stimulated growth and enhanced osteocalcin (OC) and bone sialoprotein (BSP) gene expression in human prostate cancer cells by activating a cyclic AMP (cAMP)-dependent protein kinase A signaling pathway. When β2M was overexpressed in prostate cancer cells, it induced explosive tumor growth in mouse bone through increased phosphorylated cAMP-responsive element binding protein (CREB) and activated CREB target gene expression, including OC, BSP, cyclin A, cyclin D1, and vascular endothelial growth factor. Interrupting the β2M downstream signaling pathway by injection of the β2M small interfering RNA liposome complex produced an effective regression of previously established prostate tumors in mouse bone through increased apoptosis as shown by immunohistochemistry and activation of caspase-9, caspase-3, and cleavage of poly(ADP-ribose) polymerase. These results suggest that β2M signaling is an attractive new therapeutic target for the treatment of lethal prostate cancer bone metastasis.

Original languageEnglish (US)
Pages (from-to)9108-9116
Number of pages9
JournalCancer Research
Volume66
Issue number18
DOIs
StatePublished - Sep 15 2006
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'β2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis'. Together they form a unique fingerprint.

Cite this